Full Text View
Tabular View
No Study Results Posted
Related Studies
Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation
This study has been completed.
Study NCT00169247   Information provided by Groupe Oncologie Radiotherapie Tete et Cou

First Received on September 12, 2005.   Last Updated on June 23, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Larynx Cancer
Hypopharynx Cancer
Additional conditions recognized in this trial
Carcinoma, Squamous Cell
Hypopharyngeal Neoplasms
Laryngeal Diseases
Laryngeal Neoplasms
More general conditions related to this trial
Carcinoma
Head and Neck Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Neoplasms, Squamous Cell
Otorhinolaryngologic Diseases
Otorhinolaryngologic Neoplasms
Pharyngeal Diseases
Pharyngeal Neoplasms
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Stomatognathic Diseases
Interventions listed in this trial
cetuximab
Cisplatin
Radiotherapy 70 Gy, 35 fractions
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
Groupe Oncologie Radiotherapie Tete et Cou
Groupe d'Etude des Tumeurs de la Tête Et du Cou


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services